Enerpac Tool Group (EPAC)
(Delayed Data from NYSE)
$50.90 USD
+0.26 (0.51%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $50.88 -0.02 (-0.04%) 6:50 PM ET
4-Sell of 5 4
F Value A Growth D Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$50.90 USD
+0.26 (0.51%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $50.88 -0.02 (-0.04%) 6:50 PM ET
4-Sell of 5 4
F Value A Growth D Momentum C VGM
Zacks News
Enerpac Tool (EPAC) Q1 Earnings Miss Estimates, Increase Y/Y
by Zacks Equity Research
Enerpac Tool's (EPAC) Q1 results reflect impacts of healthy demand for industrial products, weakness in services demand and macroeconomic challenges. It maintains its revenue projection for fiscal 2022.
Worthington Industries (WOR) Q2 Earnings Surpass Estimates
by Zacks Equity Research
Worthington (WOR) delivered earnings and revenue surprises of 34.18% and 1.20%, respectively, for the quarter ended November 2021. Do the numbers hold clues to what lies ahead for the stock?
Enerpac (EPAC) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Enerpac (EPAC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Applied DNA Sciences (APDN) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Applied DNA Sciences (APDN) delivered earnings and revenue surprises of -53.13% and 5.56%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Enerpac (EPAC) Up 2.5% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Enerpac (EPAC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
3 Stocks to Watch for in Prospering Manufacturing Tools Industry
by Payal Jalan
Despite supply-chain and cost woes, players in the Zacks Manufacturing-Tools & Related Products industry have been gaining from healthy operating activities. SWK, KMT and EPAC are worth a watch.
Enerpac Tool (EPAC) Lags Q4 Earnings and Sales Estimates
by Zacks Equity Research
Enerpac Tool's (EPAC) Q4 results reflect gains from healthy demand for products offered by its segments, better margins and lower taxes. It anticipates a y/y revenue increase for fiscal 2022.
Stanley Black (SWK) to Gain From Solid Demand, Costs Increase
by Zacks Equity Research
Stanley Black (SWK) is poised to benefit from solid demand, surge in e-commerce business and acquired assets. Cost inflation and transit woes are likely to hurt.
Stanley Black (SWK) to Purchase 80% Stake in MTD Holdings
by Zacks Equity Research
Stanley Black's (SWK) buyout of an 80% stake in MTD Holdings is in addition to a 20% interest acquired in 2019. The buyout is expected to boost the company's presence in the outdoor products market.
Enerpac Tool (EPAC) Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Enerpac Tool (EPAC) has been struggling lately, but the selling pressure may be coming to an end soon.
Kennametal (KMT) Q4 Earnings Beat Estimates, Increase Y/Y
by Zacks Equity Research
Kennametal's (KMT) Q4 earnings reflect gains from healthy businesses in the majority of end markets and lower taxes. High costs and expenses play spoilsport.
Why Is Enerpac (EPAC) Down 3.9% Since Last Earnings Report?
by Zacks Equity Research
Enerpac (EPAC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Stanley Black (SWK) Beats On Q2 Earnings, Hikes '21 View
by Zacks Equity Research
Stanley Black's (SWK) Q2 results gain from healthy segmental business and improved margin profile. It hikes 2021 projections on improving market conditions, solid demand and margin resiliency.
Reasons Why it is Worth Investing in Enerpac Tool (EPAC) Now
by Zacks Equity Research
Enerpac Tool (EPAC) to gain from strengthening end markets, product introductions, e-commerce business and recoveries in the global markets.
Enerpac Tool Group (EPAC): Strong Industry, Solid Earnings Estimate Revisions
by Zacks Equity Research
Enerpac Tool Group (EPAC) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Enerpac Tool (EPAC) Tops Q3 Earnings Estimates, Ups H2 View
by Zacks Equity Research
Enerpac Tool (EPAC) Q3 results reflect benefits from improving demand in end markets as restrictions related to the pandemic ease. It increases revenue projections for the second half of fiscal 2021.
Company News for Jun 30, 2021
by Zacks Equity Research
Companies in the news are: EPAC, CERE, PLBY, MRNA
Enerpac (EPAC) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Enerpac (EPAC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks Industry Outlook Highlights: Stanley Black & Decker, Lincoln Electric Holdings, Kennametal and Enerpac Tool Group
by Zacks Equity Research
Zacks Industry Outlook Highlights: Stanley Black & Decker, Lincoln Electric Holdings, Kennametal and Enerpac Tool Group
3 Manufacturing Tool Stocks With Earnings Growth Potential
by Payal Jalan
Despite the pandemic woes, players in the Zacks Manufacturing-Tools & Related Products industry are gaining from manufacturing activities. Three stocks, SWK, LECO and KMT, show healthy prospects.
Enerpac (EPAC) Up 5.2% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Enerpac (EPAC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Enerpac Tool (EPAC) to Gain From Products & Demand Amid Pandemic
by Zacks Equity Research
Enerpac Tool's (EPAC) solid product offerings, focus on innovation and improving demand in the market are expected to aid performance in the quarters ahead. The pandemic-related risks are concerning.
Company News for Mar 25, 2021
by Zacks Equity Research
Companies In The News Are: EPAC, AIR, GME, GIS
Enerpac Tool (EPAC) Lags Q2 Earnings Estimates, Gives H2 View
by Zacks Equity Research
Enerpac Tool (EPAC) Q2 results reflect the continued adverse impacts of the pandemic on operations. Expecting demand improvement, it provides revenue and other projections for the second half.
Enerpac (EPAC) Q2 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Enerpac (EPAC) delivered earnings and revenue surprises of -50.00% and -5.84%, respectively, for the quarter ended February 2021. Do the numbers hold clues to what lies ahead for the stock?